Developmental programming: Prenatal steroid excess disrupts key members of intraovarian steroidogenic pathway in sheep

Endocrinology (United States)

Volumn 155, Issue 9, 2014, Pages 3649-3660

  Padmanabhan, Vasantha ^a   Salvetti, Natalia R ^b,c   Matiller, Valentina ^b,c   Ortega, Hugo H ^b,c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSIDAD NACIONAL DEL LITORAL   (Argentina)

^c Argentine National Research Council ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

3BETA HYDROXY DELTA5 STEROID DEHYDROGENASE; ANDROSTANOLONE; AROMATASE; CYTOCHROME P450 17; ESTRADIOL; STEROID; STEROIDOGENIC ACUTE REGULATORY PROTEIN; 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE; ANDROGEN; ESTROGEN; PHOSPHOPROTEIN; STEROID 17ALPHA MONOOXYGENASE; TESTOSTERONE;

ADULT; ANIMAL CELL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ESTROGEN ACTIVITY; FEMALE; IMMUNOHISTOCHEMISTRY; NONHUMAN; OVARY FOLLICLE CELL; PHENOTYPE; PRENATAL DEVELOPMENT; PROTEIN EXPRESSION; SHEEP; THECA CELL; WESTERN BLOTTING; ANIMAL; BIOSYNTHESIS; DISEASE MODEL; DRUG EFFECT; ENVIRONMENTAL EXPOSURE; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; MALE; METABOLISM; OVARY FOLLICLE; PREGNANCY; PRENATAL EXPOSURE;

3-HYDROXYSTEROID DEHYDROGENASES; ANDROGENS; ANIMALS; AROMATASE; BIOSYNTHETIC PATHWAYS; DIHYDROTESTOSTERONE; DISEASE MODELS, ANIMAL; ESTRADIOL; ESTROGENS; FEMALE; HUMANS; MALE; MATERNAL EXPOSURE; OVARIAN FOLLICLE; PHOSPHOPROTEINS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SHEEP; STEROID 17-ALPHA-HYDROXYLASE; STEROIDS; TESTOSTERONE;

EID: 84907053794     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1266     Document Type: Article

References (66)

1. White PC. Steroid 11 β-hydroxylase deficiency and related disorders. Endocrinol Metab Clin North Am. 2001;30:61-79, vi.
2. McLachlan JA, Simpson E, Martin M. Endocrine disrupters and female reproductive health. Best Pract Res Clin Endocrinol Metab. 2006;20:63-75.
3. Padmanabhan V, Veiga-Lopez A. Developmental origin of reproductive and metabolic dysfunctions: androgenic versus estrogenic reprogramming. Semin Reprod Med. 2011;29:173-186.
4. Sibeko S, Baxter C, Yende N, Karim QA, Karim SS. Contraceptive choices, pregnancy rates, and outcomes in a microbicide trial. Obstet Gynecol. 2011;118:895-904.
5. Jellesen R, Strandberg-Larsen K, et al. Maternal use of oral contraceptives and risk of fetal death. Paediatr Perinat Epidemiol. 2008; 22:334-340.
6. Tefre de Renzy-Martin K, Frederiksen H, Christensen J, et al. Current exposure of 200 pregnant Danish women to phthalates, para-bens and phenols. Reproduction. 2014;147:443-453.
7. Hogg K, Price EM, Hanna CW, Robinson WP. Prenatal and perinatal environmental influences on the human fetal and placental epigenome. Clin Pharmacol Ther. 2012;92:716-726.
8. Swan SH. Environmental phthalate exposure in relation to reproductive outcomes and other health endpoints in humans. Environ Res. 2008;108:177-184.
9. Ranjit N, Siefert K, Padmanabhan V. Bisphenol-A and disparities in birth outcomes: a review and directions for future research. J Peri-natol. 2010;30:2-9.
10. Sir-Petermann T, Maliqueo M, Angel B, Lara HE, Pérez-Bravo F, Recabarren SE. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal an-drogenization. Hum Reprod. 2002;17:2573-2579.
11. Cattrall FR, Vollenhoven BJ, Weston GC. Anatomical evidence for in utero androgen exposure in women with polycystic ovary syndrome. Fertil Steril. 2005;84:1689-1692.
12. Beck-Peccoz P, Padmanabhan V, Baggiani AM, et al. Maturation of hypothalamic-pituitary-gonadal function in normal human fetuses: circulating levels of gonadotropins, their common a-subunit and free testosterone, and discrepancy between immunological and biological activities of circulating follicle-stimulating hormone. J Clin Endocrinol Metab. 1991;73:525-532.
13. Barbieri RL, Saltzman DH, Torday JS, Randall RW, Frigoletto FD, Ryan KJ. Elevated concentrations of the β-subunit of human chorionic gonadotropin and testosterone in amniotic fluid of gestations of diabetic mothers. Am J Obstet Gynecol. 1986;154:1039-1043.
14. Driscoll SG, Benirschke K, Curtis GW. Neonatal deaths among infants of diabetic mothers. Postmortem findings in ninety-five infants. Am J Dis Child. 1960;100:818-835.
15. Abbott DH, Nicol LE, Levine JE, Xu N, Goodarzi MO, Dumesic DA. Nonhuman primate models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:21-28.
16. McNeilly AS, Duncan WC. Rodent models of polycystic ovary syndrome. Mol Cell Endocrinol. 2013;373:2-7.
17. Padmanabhan V, Veiga-Lopez A. Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol. 2013;373:8-20.
18. Hart R, Hickey M, Franks S. Definitions, prevalence and symptoms of polycystic ovaries and polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18:671-683.
19. Dunaif A, Thomas A. Current concepts in the polycystic ovary syndrome. Annu Rev Med. 2001;52:401-419.
20. Hampton T. NIH panel: name change, new priorities advised for polycystic ovary syndrome. JAMA. 2013;309:386.
21. Padmanabhan V, Veiga-Lopez A. Animal models of the polycystic ovary syndrome phenotype. Steroids. 2013;78:734-740.
22. Veiga-Lopez A, Steckler TL, Abbott DH, et al. Developmental programming: impact of excess prenatal testosterone on intra-uterine fetal endocrine milieu and growth in sheep. Biol Reprod. 2011;84: 87-96.
23. Veiga-Lopez A, Ye W, Phillips DJ, Herkimer C, Knight PG, Padmanabhan V. Developmental programming: deficits in reproductive hormone dynamics and ovulatory outcomes in prenatal, testosterone-treated sheep. Biol Reprod. 2008;78:636-647.
24. Smith P, Steckler TL, Veiga-Lopez A, Padmanabhan V. Developmental programming: differential effects of prenatal testosterone and dihydrotestosterone on follicular recruitment, depletion of follicular reserve, and ovarian morphology in sheep. Biol Reprod. 2009;80:726-736.
25. Manikkam M, Steckler TL, Welch KB, Inskeep EK, Padmanabhan V. Fetal programming: prenatal testosterone treatment leads to follicular persistence/luteal defects; partial restoration of ovarian function by cyclic progesterone treatment. Endocrinology. 2006;147: 1997-2007.
26. Ortega HH, Salvetti NR, Padmanabhan V. Developmental programming: prenatal androgen excess disrupts ovarian steroid receptor balance. Reproduction. 2009;137:865-877.
27. Rodgers RJ. Steroidogenic cytochrome P450 enzymes and ovarian steroidogenesis. Reprod Fertil Dev. 1990;2:153-163.
28. Jamnongjit M, Hammes SR. Ovarian steroids: the good, the bad, and the signals that raise them. Cell Cycle. 2006;5:1178-1183.
29. Manikkam M, Crespi EJ, Doop DD, et al. Fetal programming: prenatal testosterone excess leads to fetal growth retardation and postnatal catch-up growth in sheep. Endocrinology. 2004;145:790-798.
30. Ortega HH, Rey F, Velazquez MM, Padmanabhan V. Developmental programming: effect of prenatal steroid excess on intraovarian components of insulin signaling pathway and related proteins in sheep. Biol Reprod. 2010;82:1065-1075.
31. Salvetti NR, Ortega HH, Veiga-Lopez A, Padmanabhan V. Developmental programming: impact of prenatal testosterone excess on ovarian cell proliferation and apoptotic factors in sheep. Biol Reprod. 2012;87:221-210.
32. Lundy T, Smith P, O'Connell A, Hudson NL, McNatty KP. Populations of granulosa cells in small follicles of the sheep ovary. J Reprod Fertil. 1999;115:251-262.
33. Quirke LD, Juengel JL, Tisdall DJ, Lun S, Heath DA, McNatty KP. Ontogeny of steroidogenesis in the fetal sheep gonad. Biol Reprod. 2001;65:216-228.
34. Zlotkin T, Farkash Y, Orly J. Cell-specific expression of immuno-reactive cholesterol side-chain cleavage cytochrome P-450 during follicular development in the rat ovary. Endocrinology. 1986;119: 2809-2820.
35. Ishimura K, Yoshinaga-Hirabayashi T, Tsuri H, Fujita H, Osawa Y. Further immunocytochemical study on the localization of aroma-tase in the ovary of rats and mice. Histochemistry. 1989;90:413-416.
36. Rodgers RJ, Rodgers HF, Hall PF, Waterman MR, Simpson ER. Immunolocalization of cholesterol side-chain cleavage cytochrome P-450 an 17 a-hydroxylase cytochrome P-450 in bovine ovarian follicles. J Reprod Fertil. 1986;78:627-638.
37. Zhong C, Ishimura K, Yoshinaga-Hirabayashi T, Fujita H, Kit-awaki J, Osawa Y. Immunocytochemical study on the localization of aromatase in the ovary of golden hamster, guinea pig and cow. Acta Histochem Cytochem. 1989;22:501-507.
38. Xu Z, Garverick HA, Smith GW, Smith MF, Hamilton SA, Youngquist RS. Expression of messenger ribonucleic acid encoding cytochrome P450 side-chain cleavage, cytochrome p450 17 a-hy-droxylase, and cytochrome P450 aromatase in bovine follicles during the first follicular wave. Endocrinology. 1995;136:981-989.
39. Meduri G, Vu Hai MT, Jolivet A, et al. Comparison of cellular distribution of LH receptors and steroidogenic enzymes in the porcine ovary. J Endocrinol. 1996;148:435-446.
40. Sasano H, Okamoto M, Mason JI, et al. Immunolocalization of aromatase, 17 a-hydroxylase and side-chain-cleavage cytochromes P-450 in the human ovary. J Reprod Fertil. 1989;85:163-169.
41. Tamura T, Kitawaki J, Yamamoto T, et al. Immunohistochemical localization of 17 a-hydroxylase/C17-20 lyase and aromatase cytochrome P-450 in the human ovary during the menstrual cycle. J Endocrinol. 1992;135:589-595.
42. Logan KA, Juengel JL, McNatty KP. Onset of steroidogenic enzyme gene expression during ovarian follicular development in sheep. Biol Reprod. 2002;66:906-916.
43. McNatty KP, Reader K, Smith P, Heath DA, Juengel JL. Control of ovarian follicular development to the gonadotrophin-dependent phase: a 2006 perspective. Soc Reprod Fertil Suppl. 2007;64:55-68.
44. McNatty KP, Kieboom LE, McDiarmid J, Heath DA, Lun S. Adenosine cyclic 3', 5'-monophosphate and steroid production by small ovarian follicles from Booroola ewes with and without a fecundity gene. J Reprod Fertil. 1986;76:471-480.
45. Amalfi S, Velez LM, Heber MF, et al. Prenatal hyperandrogeniza-tion induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PloS ONE. 2012;7:e37658.
46. Zurvarra FM, Salvetti NR, Mason JI, Velazquez MM, Alfaro NS, Ortega HH. Disruption in the expression and immunolocalisation of steroid receptors and steroidogenic enzymes in letrozole-induced polycystic ovaries in rat. Reprod Fertil Dev. 2009;21:827-839.
47. Ortega I, Sokalska A, Villanueva JA, et al. Letrozole increases ovarian growth and Cyp17a1 gene expression in the rat ovary. Fertil Steril. 2013;99:889-896.
48. Hogg K, Young JM, Oliver EM, Souza CJ, McNeilly AS, Duncan WC. Enhanced thecal androgen production is prenatally programmed in an ovine model of polycystic ovary syndrome. Endocrinology. 2012;153:450-461.
49. Hogg K, McNeilly AS, Duncan WC. Prenatal androgen exposure leads to alterations in gene and protein expression in the ovine fetal ovary. Endocrinology. 2011;152:2048-2059.
50. Sawyer HR, Smith P, Heath DA, Juengel JL, Wakefield SJ, McNatty KP. Formation of ovarian follicles during fetal development in sheep. Biol Reprod. 2002;66:1134-1150.
51. West C, Foster DL, Evans NP, Robinson J, Padmanabhan V. Intra-follicular activin availability is altered in prenatally-androgenized lambs. Mol Cell Endocrinol. 2001;185:51-59.
52. Steckler T, Manikkam M, Inskeep EK, Padmanabhan V. Developmental programming: follicular persistence in prenatal testosterone-treated sheep is not programmed by androgenic actions of testosterone. Endocrinology. 2007;148:3532-3540.
53. Hough D, Cloete SW, Storbeck K, Swart AC, Swart P. Cortisol production in sheep is influenced by the functional expression of two cytochrome P450 17a-hydroxylase/17, 20-lyase (CYP17) isoforms. J Anim Sci. 2013;91:1193-1206.
54. Akhtar MK, Kelly SL, Kaderbhai MA. Cytochrome b(5) modulation of 17a hydroxylase and 17-20 lyase (CYP17) activities in steroidogenesis. J Endocrinol. 2005;187:267-274.
55. Luense LJ, Veiga-Lopez A, Padmanabhan V, Christenson LK. Developmental programming: gestational testosterone treatment alters fetal ovarian gene expression. Endocrinology. 2011;152:4974-4983.
56. Lin W, Song ZJ, Sun WM, et al. [Expression of steroidogenic enzymes in the rat model of polycystic ovary syndrome]. Sheng Li Xue Bao. 2013;65:171-177.
57. Veiga-Lopez A, Ye W, Padmanabhan V. Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles. Fertil Steril. 2012;97: 748-756.
58. Jakimiuk AJ, Weitsman SR, Navab A, Magoffin DA. Luteinizing hormone receptor, steroidogenesis acute regulatory protein, and steroidogenic enzyme messenger ribonucleic acids are overexpressed in thecal and granulosa cells from polycystic ovaries. J Clin Endocrinol Metab. 2001;86:1318-1323.
59. Wickenheisser JK, Velen L, Nelson-Degrave VL, McAllister JM. Dysregulation of cytochrome P450 17a-hydroxylase messenger ribonucleic acid stability in theca cells isolated from women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2005;90: 1720-1727.
60. Nelson VL, Qin KN, Rosenfield RL, et al. The biochemical basis for increased testosterone production in theca cells propagated from patients with polycystic ovary syndrome. J Clin Endocrinol Metab. 2001;86:5925-5933.
61. Daneshmand S, Weitsman SR, Navab A, Jakimiuk AJ, Magoffin DA. Overexpression of theca-cell messenger RNA in polycystic ovary syndrome does not correlate with polymorphisms in the cholesterol side-chain cleavage and 17a-hydroxylase/C(17-20) lyase promoters. Fertil Steril. 2002;77:274-280.
62. Sander VA, Hapon MB, Sícaro L, Lombardi EP, Jahn GA, Motta AB. Alterations of folliculogenesis in women with polycystic ovary syndrome. Steroid Biochem Mol Biol. 2011;124:58-64.
63. Wickenheisser JK, Nelson-DeGrave VL, McAllister JM. Human ovarian theca cells in culture. Trends Endocrinol Metab. 2006;17: 65-71.
64. Comim FV, Teerds K, Hardy K, Franks S. Increased protein expression of LHCG receptor and 17a-hydroxylase/17-20-lyase in human polycystic ovaries. Human Reproduction. 2013;28:3086-3092.
65. Chua AK, Azziz R, Goodarzi MO. Association study of CYP17 and HSD11B1 in polycystic ovary syndrome utilizing comprehensive gene coverage. Mol Hum Reprod. 2012;18:320-324.
66. Jakimiuk AJ, Weitsman SR, Brzechffa PR, Magoffin DA. Aromatase mRNA expression in individual follicles from polycystic ovaries. Mol Hum Reprod. 1998;4:1-8.